Dr. Barrionuevo, is subspecialty certified in Reproductive Endocrinology and Infertility with over 25 years experience in the diagnosis and treatment of female and male infertility and is the current president of IVF FLORIDA Reproductive Associates.
He completed his fellowship in Reproductive Endocrinology and Infertility at the University of South Florida, College of Medicine in Tampa, Florida and after joining IVF FLORIDA in 1998, he has served as president of the Miami Obstetrics and Gynecology Society (MOGS), president of the Florida Society of Reproductive Endocrinology and Infertility (FSREI) and Florida-District XII Section 6 chair in the American College of Obstetrics and Gynecology (ACOG).
Dr. Barrionuevo is a founding member of the Latin American Society of Reproductive Medicine (ALMER), member in the advisory Board of ALMER since 2018, as well as a voluntary Clinical Professor at the University of Miami (UM), Florida International University (FIU) and Florida Atlantic University (FAU).
Dr Chavez-Badiola is the current CEO at IVF 2.0, a technology company dedicated to bringing a new generation of technologies to the benchside, focusing on the intersection of Reproductive Medicine and Artificial intelligence.
After graduating with honours from Medical School and becoming a specialist in ObGyn (2004), he received his training in Reproductive Medicine in the UK and has dedicated 15 years as Medical Director at New Hope Fertility Center in Mexico.
His current interest is focused on the use of AI to assist sperm selection for ICSI in real-time (SiD), the AI evaluation of oocyte impact on embryo quality (AIR-o), and how Augmented Intelligence (Human-Machine interaction) during the embryo selection process using ERICA, can improve embryologists’ performance.
Sandy Christiansen is a certified clinical embryologist who worked in IVF clinics in Sweden and London for more than ten years. She started her own business as a fertility coach to support people through fertility treatments and also works for an American fertility benefits company and the medical team at Béa Fertility.
Amander Clark is Department Chair and Professor of Molecular Cell and Developmental Biology at UCLA. She is an expert in Stem Cell Biology with an emphasis on using stem cells to understand fertility and infertility. She has published over 100 peer-reviewed articles in this area and is a sought after speaker on the topics of stem cell biology and international stem cell policy.
Dr. Urmila Diwekar is the President of Stochastic Research Technologies LLC. Also, the president of the Vishwamitra Research, a non-profit research institute that she founded to pursue multidisciplinary research. From 2002-2004, she was a Professor in the Departments of Chemical Engineering, Bio-Engineering, and Industrial Engineering, and in the Institute for Environmental Science and Policy, at the University of Illinois at Chicago (UIC). She has a special formal arrangement with UIC, where she remains as the main advisor for her Ph.D. and M.S. students and teaches a course on optimization. From 1991-2002 she was on the faculty of the Carnegie Mellon University, with early promotions to both the Associate and the Full Professor level. She is the author of more than 190 peer-reviewed research papers, has given over 420 presentations and seminars, and has chaired numerous sessions in national and international meetings. She has been the principal advisor to 45 Ph.D. and M.S. students and has advised 15 post-doctoral fellows and researchers.
After undergoing several IVF cycles herself, she realized the physical, economic, and emotional toll it takes on a woman to undergo this treatment. To reduce this burden, she started her work on customizing optimal dosage for each patient of IVF with minimal testing, which resulted in the decision support tool OptIVF. Early clinical trials in India showed the promise of this approach in reducing drug dosage, reducing testing, and enhancing the success of IVF. This approach is shown to reduce daily testing and the cost of medications and predict optimal custom dosages for each patient. Preparations for larger clinical trials in the United States are now underway. The revolutionary impact of this work earned her the NESIN best researcher award in 2020 from ScienceFather International.
Prof Panagiotis Drakopoulos is recognized as a subspecialist in reproductive medicine and surgery by ESHRE (European society of Human Reproduction and Embryology) ). He has authored more than 80 scientific publications in international peer reviewed journals and is an invited speaker at several international IVF conferences on an annual basis. Dr Drakopoulos is Professor at the University of Brussels (VUB) and the University of Alexandria (Egypt). He also works in private, and his office is found in Athens, Greece.
Dr. Francesca E. Duncan earned her doctorate in Cell and Molecular Biology from the University of Pennsylvania and completed post-doctoral fellowships in reproductive science and medicine at the University of Pennsylvania and at Northwestern University. She is currently an Assistant Professor in the Department of Obstetrics and Gynecology in the Feinberg School of Medicine at Northwestern University and Co-Director of the Center for Reproductive Science. She also holds an Assistant Professor-in-Residence position at the Buck Institute for Research on Aging in the Center for Reproductive Longevity and Equality. Dr. Duncan leads a research program focused on understanding the cellular mechanisms of how aging – both physiologic and iatrogenic – impacts reproductive potential at the levels of the gamete and ovary. Most recently, as the Principal Investigator of the Ovarian Contraceptive Discovery Initiative, Dr. Duncan has expanded her research to encompass modulating reproductive capacity through identification of novel targets for non-hormonal contraception in the ovary using innovative models such as in vitro follicle growth and ovulation. She has co-authored >80 manuscripts in the area of reproductive biology, and her work has been highlighted on BBC radio, in Discover Magazine, and by the Faculty of 1000. Dr. Duncan is the recipient of several honors including a 2017 United States Fulbright Award and the 2019 Virendra B. Mahesh New Investigator Award from the Society for the Study of Reproduction.
Jullin Fjeldstad began her fertility career in a Canadian IVF clinic in 2007, quickly becoming a senior embryologist and successfully holding the position of laboratory director for several years. She has a Bachelor of Science in Biology from the University of Victoria, Canada and a Master of Science in Clinical Embryology from the University of Leeds, UK, achieving distinction in both areas. Today, Jullin is the Head of Customer Service and Embryology for Future Fertility in Toronto, Canada.
Dr. Jason Franasiak, MD, FACOG, HCLD/ALD (ABB) is an attending physician at Reproductive Medicine Associates of New Jersey where he serves as lead physician and high complexity laboratory director of the embryology and andrology labs at the Marlton office, Assistant Professor at Thomas Jefferson University in the Department of Obstetrics and Gynecology, Clinical Assistant Professor at Rutgers Robert Wood Johnson Medical School, and Medical Director for the Liberty Corner Ambulatory Surgical Center at Marlton. Dr. Franasiak is regularly invited to speak at the regional, national, and international level and has authored and contributed to nearly 200 peer reviewed publications, published chapters, and abstracts. He serves as the editor of a textbook on recurrent implantation failure, on the Editorial Board for Fertility and Sterility and the British Journal of Obstetrics and Gynecology, and has served on the executive board of the Society for Reproductive Endocrinology and Infertility.
David is the Scientific Director of Melbourne IVF and a Distinguished Professor in the School of BioSciences, University of Melbourne.
He completed his PhD (1987) at the University of York. In 1988 he moved to Harvard Medical School, after which he moved to Monash, Australia, in 1989. In 1997 became the Scientific Director of the Colorado Centre for Reproductive Medicine in Denver, where his work on human embryo culture conditions revolutionised how human IVF is performed today with the introduction of blastocyst transfer.
In 2007 he was appointed Professor and Chair of Department at the University of Melbourne and promoted to the level of Distinguished Professor in 2018. In 2017 he became the Scientific Director of Melbourne IVF. He has published 300 papers and chapters and has edited 15 books, culminating in over 30,000 citations and an H index of 99.
In 2017 in recognition of his many significant contributions to reproductive sciences he was elected as a Fellow into the Australian Academy of Science (FAA) and further was the recipient of the Distinguished Researcher Award from the American Society of Reproductive Medicine.
Dr. Luca Gianaroli is specialist in Reproductive Medicine since the end of the Seventies. He is the Scientific Director of S.I.S.Me.R. (Italian Society for the Study of Reproductive Medicine) and he holds the position of Scientific Director of IIIRM SA in Lugano, Switzerland. He is also Honorary Professor at the School of Biosciences of the University of Kent.
Active member of several international scientific societies in which he has covered and currently covers roles of primary importance, he has served as Chairman of the Italian Society of Reproduction and of the European Society of Human Reproduction and Embryology (ESHRE). At present, he is a member of the ESHRE Certification Committee, of the ESHRE COVID-19 Working Group and he is the immediate past coordinator of the Steering Committee of the ESHRE ART Centre Certification Program.
From 2015 to 2017, he served as Chairman of SIOS.E (Italian Society of Sterility and Embriology). In 2017, he was one of the founders of the Fondazione PMA.Italia (PMA.Italia Foundation), of which he is currently the Vice-President.
From the 1st January 2021 he is Director of Global Educational Programs of the International Federation of Fertility Societies (IFFS)
In 2014 he was appointed as Fellow ad eundem of the Royal College of Obstetricians and Gynaecologists. In the same year he obtained the Italian Abilitazione Scientifica Nazionale (National Scientific License) as Ordinary Professor – I category, which was renewed in 2020.
Dr. Gianaroli is author of more than 250 papers in international scientific journals and publisher or co-publisher of 9 books. As of the date of this biosketch his H-index is 77 (Google Scholar).
Throughout his professional career he collaborated with several universities in Italy (Università degli Studi di Teramo, Università degli Studi di Modena e Reggio Emilia, Università degli Studi di Trieste, Università degli Studi di Roma Tor Vergata, Università di Bologna) and abroad (Leuven University in Belgium, Monash University in Australia and Geneva University in Switzerland).
Dr. Gleicher has served as founding Editor-in-Chief for the American Journal of Reproductive Immunology (AJRI), and for 30 years of the Journal of In Vitro Fertilization and Embryo Transfer, in 1992 renamed Journal of Assisted Reproduction and Genetics (JARG), now the 2nd official organ of the American Society for Reproductive Medicine (ASRM). In 1991, he was awarded Austrian Decoration for Science and Art for his work. In 2009, Dr. Gleicher was invited to give the prestigious bi-annual Patrick Steptoe Memorial Lecture to the British Fertility Society, as recognition of his contributions to advancements in reproductive endocrinology and infertility.
Roger Gosden trained in reproductive science under Robert Edwards in Cambridge. More than twenty years after leading research groups in Edinburgh and Leeds, UK, he moved to North America. There he worked with Howard W. Jones, Jr., married the embryologist Lucinda Veeck and continued research at Weill Cornell Medical College in NYC.
Dr Cristina Hickman is the VP of Clinical Affairs at Fairtility, Co-Founder of Aria Fertility (a clinic in London), lecturer at Imperial College London, a consultant for IVF Professionals and CSO at Apricity. Following her PhD in Embryology from University of Edinburgh, Cristina has been a lab director for 11 years, and has built 12 IVF clinics worldwide, including Boston Place Clinic, the first clinic designed around time-lapse, and Aria Fertilty, the first clinic designed around digitisation. Cristina has 11 years experience working with AI and Fertility.
Dr Eran Horowitz works as a Senior Physician in the IVF unit, Wolfson Medical Center, Holon, Sackler Faculty of Medicine, Tel Aviv University, Israel, where he currently holds the position of Senior Lecturer. Dr Horowitz has published more than 40 scientific papers and chapters in books.
Tsafrir Kolatt is a co-founder and the CEO of Fertigo Medical, a company devoted to increase the success rate in In-vitro Fertilization procedures.
Prior to that Kolatt has led a few medical device and bio-medical companies, private and public, where he developed and brought to market new, successful devices for both therapy and diagnosis.
Dr. Kolatt got his Ph.D. in theoretical astrophysics from the Hebrew University in Jerusalem and was a researcher at Harvard University and UCSC. Kolatt published a few books, dozens of scientific papers, issued a few patents and many popular articles. He won numerous scholarships and prizes for research, innovative product development, poetry and play-writing. He also serves as the chairperson of IYAR – the Israeli Institute for Advanced Research.
Elena Labarta, MD, PhD, is a gynaecologist specialized in assisted reproduction treatments working in the Instituto Valenciano de Infertilidad (IVI) in Valencia since 2005. She combines clinical practice with research activity, being part of the IVI Foundation team. Dr Labarta is Profesor of the MSc in the Biotechnology of Human Assisted Reproduction and Embryology. She is a frequent lecturer.
Prof. Milton Ka Hong Leong was brought up in Hong Kong, finished his basic school years, and then went to attend McGill University in Montreal Canada. He did Honours Biochemistry as an undergraduate, and then Medical School. Further postgraduate training in Obstetrics and Gynecology followed, and he obtained his specialists degree in 1974. He then went to London on a McLaughlin Fellowship granted by the Canadian Royal College where he studied under Professors Richard Beard and Stuart Campbell. Returning to Montreal, he joined the McGill University Department as academic staff, and was active in teaching and also headed the High Risk Obstetric Unit.
In 1979 Prof. Leong returned to Hong Kong and engaged in private practice. Seeing a need at that time, he started to concentrate in the study and treatment of Infertility. He set up the IVF Centre at the Hong Kong Sanatorium and Hospital, a private hospital, in joint venture form, and with his partner Dr Clement Leung, they built it up to be one of the most successful IVF clinics in Asia and the world. He “made” and delivered the first IVF baby in Hong Kong in 1985,and in the last 20 years had researched, published, and taught the art and science of infertility and the assisted reproductive techniques.
Prof. Leong is a member of the various reproductive medicine societies, and various international committees. He lecture widely, and still plays an active academic role, and remains to be an Adjunct Professor of Obstetrics and Gynecology in McGill University. His current interest is how to provide the optimal treatment for infertile patients using a patient orientated, more holistic approach.
Mattan Levi is a translational research director at QART Medical, IVF lab director at Meir medical center and visiting scientist at Prof. Shaked laboratory at Tel Aviv University. Mattan Levi’s research in the fields of reproductive and cancer biology included postdoctoral studies at Prof. Shalgi laboratory at Tel Aviv University, fellowship at the Sorbonne University consortium and foundation and management of both medical andrology laboratory at Herzliya Medical Center and oncology research laboratory at Rabin Medical center in Israel.
Professor Dror Meirow is the chair of the Morris Kahn Center for Fertility Preservation Division of Obstetrics and Gynecology, at Sheba Medical Center, Tel-Hashomer, Israel. He is a Professor at the Sackler Faculty of Medicine, Tel-Aviv University, Israel. Former President of the International Society of Fertility Preservation (ISFP).
Prof. Meirow received his M.D. from the Hebrew University, Jerusalem, Israel. He then specialized and practiced as a senior physician in Obstetrics and Gynecology at Hadassah University Hospital. He conducted his basic research training at the Center for Reproduction Growth and Development with Prof. Roger Gosden at the University Leeds, UK. Since 2001, Prof Meirow founded the Clinical Center for Fertility Preservation and the Fertility Preservation Research Laboratory at Sheba Medical Center, Tel Hashomer Israel.
Professor Meirow’s basic and clinical research is focused on the effects of chemotherapy on reproduction, and modalities for fertility preservation especially on ovarian tissue harvesting for fertility preservation, and medications that can prevent chemotherapy-induced ovarian damage. Prof. Meirow reported in the New England Journal of Medicine the first case of IVF, pregnancy, and delivery of a healthy baby to result from transplantation of cryopreserved thawed ovarian tissue in a sterilized former cancer patient. Prof. Meirow’s laboratory team published a pioneer study in Science Journal providing a new understanding of the “Burn-out” mechanisms involved in chemotherapy-induced ovarian damage, and testing a novel fertility-protecting agent.
My name is Tamanna Mohammadi, master’s degree in Biomedicine, graduated from Southern University of Denmark. I performed my master’s thesis in Beijing at Chinese Academy of Sciences, investigating the role of M6A RNA modification in Planarian regeneration. Currently I’m working with clinical analysis at Amplexa Genetics.
Mary Morris, MD, PhD, is the Medical Director of the Oncofertility Clinic and the Medical Director of the Third-Party Reproduction Program in the Reproductive Endocrinology and Infertility Division of the Department of Obstetrics and Gynecology at Massachusetts General Hospital. She is an Assistant Professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School.
Her primary research interests include exploring novel approaches to fertility preservation in those diagnosed with cancer and understanding clinical outcomes for women with hereditary cancer syndromes.
Jodi Neuhauser is a global entrepreneur, investor and advisor to femtech companies with a focus on integrated approaches to lifestyle-based care. Currently, Ms. Neuhauser is the Co-Founder and CEO of Ovaterra, the first science-backed preconception marketplace for fertility and the maker of the industry-leading FERTINATAL DHEA. Ovaterra’s proprietary technology matches patients to the products they need based on where they are in their journey. Jodi has experience in product, development, marketing, brand and sales across 5 continents in PE and VC-backed companies and is a regular guest lecturer at The University of Virginia.
Dr Helen O’Neill is CEO and Founder of Hertility Health, an innovative health tech company that applies a precision medicine-based approach to reproductive health. She founded Hertility Health to enable women to make informed decisions about their fertility and gain insights into their reproductive and genetic health.
She has a tenured position at University College London where she lectures both masters and medical students in reproductive and molecular genetics. Dr O’Neill was awarded in the Top Twenty Women in Data, 2019.
Dr. Orwig is a Professor of Obstetrics, Gynecology and Reproductive Sciences at the University of Pittsburgh School of Medicine. He is also the director of the Fertility Preservation Program and the Center for Reproduction and Transplantation at Magee-Womens Hospital of UPMC. Research in the Orwig laboratory focuses on stem cells, germ lineage development, fertility and infertility. Our progress investigating reproductive function in fertile individuals provides a basis for understanding the mechanisms of infertility caused by disease, medical treatments, genetic defects or aging. Infertility impacts one in seven couples in the United States and can have a devastating impact on relationships, emotional well-being and overall health. The Orwig lab is ideally located in Magee-Womens Research Institute and Magee-Womens Hospital of the University of Pittsburgh and is committed to translating lab bench discoveries to the clinic for diagnosis, prevention and treatment of infertility.
Hannah Pierson completed her PhD in biomolecular chemistry in 2013. Subsequently She was recruited to the Johns Hopkins Medical Institute where she worked as an epithelial cell biologist for about 5 years. During her research fellowship, she led projects on 3D epithelial organoid tissue models and development of new image-based methods for real-time mechanistic tissue level investigations. Hannah Pierson specialization in epithelial cell biology, advanced imaging technologies, and computational approaches to image analytics positioned her well to assume the role of Senior Scientist at Synergyne ART Analytics Inc. Hannah Pierson has been in this role since 2018.
Dr. Polyzos is the Head of Reproductive Medicine Department of Dexeus Mujer, at Dexeus University Hospital in Barcelona Spain and a Visiting Professor in the Department of Reproductive Medicine in the University of Gent in Belgium. Since 2021, he is a member of the Executive Committee (ExCO) of the European Society of Human Reproduction and Embryology (ESHRE).
He has served as a Medical Director in the Centre for Reproductive Medicine in Brussels until 2017, as a Professor of Obstetrics and Gynaecology in the Free University of Brussels (VUB) until 2019 and as Professor of Reproductive Endocrinology in the Department of Clinical Medicine in the University of Aarhus in Denmark until 2020.
Professor Polyzos is the principal investigator in several large pioneering multinational trials and a key opinion leader in the field of Reproductive Medicine for the treatment of poor ovarian responders in IVF programs, prediction of ovarian response and premature ovarian ageing, with more than 200 invited lectures in international congresses.
He is a Section Editor in RBMO, member of the ESHRE guideline development group for ovarian stimulation and has served as an Editorial Consultant for the PIER (Physician’s Information and Education Resource) of the American College of Physicians (ACP).
Professor Polyzos has published ~200 publications in peer-reviewed journals indexed in Pubmed with more than >8000 citations and an h index of 51 in Google Scholar. His research interests include reproductive endocrinology, ovarian reserve markers, poor ovarian response to stimulation and genetics of premature ovarian aging.
Dr Nadia Prisant is a French MD, specialized in Laboratory Fertility Medicine. After studying medicine at Paris V, completing a residency at the Lyon I-Claude Bernard Faculty and a Fertility Medecine Fellowship at the Pitie Salpetriere Hospital in Paris, she was Lab Director at Laboratoire d’Eylau, Clinique de la Muette, before joining the team of the only public IVF Laboratory in the French Caribbean.
She holds 2 master’s degrees in Infertility Medicine and Research as well as Degrees in Medical Hypnosis, Sexual Therapy and Andrology and an MBA from Reichman University in Israel. Former General Secretary of the SALF (Societe d’Andrologie de Langue Française) and a member of several Medical Societies, she has published medical papers in peer reviewed medical journals, and spoken at medical conferences around the world, notably on the emergence of the Zika virus epidemic in the Caribbean and its impact on human fertility.
Cofounder and Chief Medical Officer of IMMA health, an Israeli Femtech venture, creating a comprehensive solution for transvaginal scans from home, in non-expert hands. IMMA won MassChallenge Israel 2021 and is currently part of Microsoft-Yazamiyot accelerator in Tel Aviv.
Chief Medical Geneticist and PGT Lab director at CRAFT hospital India established heads the PGD laboratory and takes in charge of all the high end genetic testing based on NGS . Has the credibility of performing first time in INDIA PGD on a tay sach carrier couple and thereby reporting INDIA’S first live birth on a rare mutation for tay sachs. India’s first and world’s second achondroplasia free baby born after PGD . Successful first time attempt in India for a delivery of SMN free baby. Have also reported many successful cases of PGD/PGS for chromosomal translocations . Invited as a faculty in many national conferences. Recently feliciated as champion of ISAR year 2020. Has published many chapters and articles in reputed journals and books. Was a part of PGD consensus to frame guidelines for the country as an initiative from ISAR( Indian society of assisted reproduction ).
Prof. Irit Sagi is Vice President for Innovation and Technology Transfer at the Weizmann Institute of Science and a member of the Department of Biological Regulation. In her research, she develops and applies unique biophysical approaches to investigate the molecular processes of tissue and extracellular remodeling. She has done breakthrough work on the complex dynamic molecular nature of a set of enzymes that are closely linked to developmental biology, cancer, inflammation, fibrosis, and infectious diseases. She previously served as Dean of the Weizmann Institute’s Feinberg Graduate School and has received numerous prestigious awards for her research.
Dr. Denny Sakkas received his undergraduate training at the University of Melbourne, Australia and received his Doctorate of Philosophy at Monash University, Melbourne, Australia. He has been the Laboratory Director of IVF units in Europe and the USA and has extensive experience in clinical IVF and reproductive research. Dr Sakkas is currently Chief Scientific Officer at Boston IVF and remains as an Associate Professor at the Department of Obstetrics, Gynecology and Reproductive Sciences at the Yale University School of Medicine.
Ula Sankowska, Chief Operating Officer at MIM Solutions. Manager with over 15 years of experience in the public and private sectors. Since 2019, she has been co-leading the technological startup MIM Solutions, where she focuses on building and implementing AI products for business and healthcare. Initiator of the FOLLISCAN and EMBRYOAID MedFemTech projects.
Professor Zeev Shoham serves as the head of the Fertility and IVF Unit at the Kaplan Medical center in Rehovot, Israel.
Professor Shoham was born and raised in Jerusalem, Israel. He received his M.D. degree from the Hadassah Medical Center in 1981. Later completing, his residency at Kaplan Hospital in Rehovot, and his fellowship in infertility and in vitro fertilization at Tel – Hashomer Hospital and MIDDLESEX Hospital in London, UK. Since 1988 he has specialized in a wide range of treatments including:
Fertility treatments, in vitro fertilization, oocyte retrieval preservation and freezing, donor eggs and sperm, care for women during pregnancy and follow-up and treatment of postmenopausal women.
In 1991 Prof. Shoham received an award from the European Society of Human Reproduction and Embryology for the best scientific research that year in Europe for his work on stimulating sperm production by adding GH to treatment with gonadotropins in patients with hypogonadotropic hypogonadism.
Professor Shoham has published over 140 papers in the field of Reproductive Medicine, and his publications had won international awards. In addition, he has contributed chapters to numerous books. He is the editor/ author of the textbook, Female Infertility Therapy: Current Practice (1999), and one of the four editors of the textbook, Assisted Reproductive Techniques, which is at its fourth edition.
Professor Shoham is the co-founder of IVF-Worldwide the most comprehensive website on in-vitro fertilization. Professor Shoham has been organizing internationals medical conferences for the past 18 years and is a lecturer in many conferences in the field.
Dr. Tan is a Full Professor and holds the James Edmund Dodds endowed chair in the Department of Obstetrics and Gynecology at McGill University. He served as Chairman of Department from December 1994 to June 2010. During his time in this position he created 3 endowed chairs and 8 named fellowships.
An internationally recognized infertility expert and a pioneer in the simplification of in-vitro fertilization (IVF), Dr. Tan was trained and mentored in London, UK, by Professor Robert Edwards, the inventor of IVF and 2010 Nobel Laureate in Medicine.
In 1996 Dr. Tan founded the McGill Reproductive Centre (MRC), serving as its Medical Director until June 2010. He led the team that has produced 10 world or Canadian firsts—including the world’s first air transport IVF and ICSI pregnancies—and is a pioneer in Canada in the use of IVM of human oocytes for the treatment of infertility and vitrification of oocytes to preserve fertility in cancer patients. In 2005, the team was the first in the world to achieve a livebirth from an egg that was matured through IVM, vitrified and then thawed. Work performed by members of his team has been published in prestigious scientific journals including Nature, the New England Journal of Medicine and The Lancet.
In August 2010, Dr. Tan founded the Montreal Reproductive Centre, now known as OriginElle Fertility Clinic and Women’s Health Centre, which aims to combine the clinical and scientific excellence achieved at the MRC with the same personalized service provided by Drs. Tan and Edwards at the clinic they founded in London.
Dr. Tan has published 17 books and over 400 original scientific papers, book chapters and review articles. He has been on the editorial board of nine medical journals and is a member of the FIGO and Gynecology Expert Advisory Panels on Reproductive Medicine and Ultrasound and a fellow of the International Academy on Human Reproduction. In 2008, he received the Singapore Lecture Gold Medal from the Royal College of Obstetricians and Gynecologists of the United Kingdom in recognition of his significant scientific contribution to the field of obstetrics and gynecology. He received the 1999 Resolve Award from the National Infertility Association of the United States for outstanding contribution in the field of ultrasound. He has also been awarded the Howard Eddy Gold Medal by the Royal Australasian College of Surgeons and the MRCOG Gold Medal by the Royal College of Obstetricians and Gynecologists in the United Kingdom. In 2003, he earned an MBA degree with distinction from the New York University/London School of Economics/HEC Grande Ecole Paris TRIUM Executive MBA Program.
Dr. Hugh Taylor is the Anita O’Keeffe Young Professor and the chair of the Department of Obstetrics, Gynecology and Reproductive Sciences at the Yale School of Medicine. He is the immediate pas president of the American Society for Reproductive Medicine. He has published over 400 papers in the fields of basic reproductive biology and clinical medicine. He is contributed to our understanding of uterine development, endometrial receptivity and endometriosis.
Nathan Treff received his PhD in Biochemistry in 2003 and performed postdoctoral fellowships in embryonic stem cell biology and reproductive genetics at the University of Wisconsin and EMD Serono. He is currently the CSO of Genomic Prediction and Reprocare Genetics Scandinavia, Board Certified in Molecular Diagnostics as a High Complexity Laboratory Director, an Associate Professor at Rutgers University, and a Senior Editor of Fertility and Sterility Science and JARG. Dr. Treff has published over 100 peer reviewed papers in reproductive genetics and has served as a member of the ASRM Research Committee for 5 years. His work has focused on development and validation of comprehensive genomic analyses in the preimplantation embryo. For his research, he received 6 prize paper awards from the ASRM, the 2013 Ira and Ester Rosenwaks Young Investigator Award, the 2013 Bonei Olam Scientific Achievement Award, a 2014 EMD Serono Grant for Fertility Innovation, and an NIH RO1 co-investigator grant. As a cofounder of Genomic Prediction, his recent published work on PGT for polygenic disease risk has been reported on by the Wall Street Journal, Netfilx, Forbes, the Economist, Nature News, MIT Technology Review, and the European Commission. Genomic Prediction recently received the New Jersey Tech Council’s Emerging Company of the Year award in 2019.
He was a pioneer of human in vitro fertilisation (IVF) (1977-1996) and led the Australian team in the discovery of human embryonic stem cells in the late 1990’s.
He is the past President of the Californian Institute for Regenerative Medicine (2007-2014)
He is also the founding (2016) CEO of Cartherics Pty Ltd. (www.cartherics.com) developing CAR-T therapies for treating cancer using patients own T cells and immune killer cells (T-cells and NK cells) derived from iPS cells.
Ilan Tur-Kaspa, MD, FACOG, is the Founder and Medical Director of the Institute for Human Reproduction (IHR) in Chicago and Oakbrook, Illinois, and in Indiana, USA. He specializes in the use of AI to optimize ART outcome, advanced infertility treatments, preimplantation genetic testing (PGT) and reproductive imaging. In addition to the thousands of IVF cycles he personally conducted over the years, over 2500 were IVF/ICSI-PGT cycles for single gene disorders, translocations, HLA typing and aneuploidy. He is the author and co-author of over 110 scientific publications and book chapters, and he is a co-Editor of two books: ‘Biotechnology of Human Reproduction’ and ‘Ultrasound Imaging in Reproductive Medicine’. Dr Tur-Kaspa is the 2021-2022 Chair of the Reproductive Imaging Special Interest Group of the American Society of Reproductive Medicine and he served as the President of the Chicago Association of Reproductive Endocrinologists.
Professor Ariel Weissman graduated the Hadassah-Hebrew University Medical School in 1988. In 1994 he completed his residency in Obstetrics and Gynecology at the Kaplan Medical Center, Rehovot, where he spent another two years working as a senior physician at the IVF unit. Prof. Weissman then pursued a 2-year research and clinical fellowship with Prof. Bob Casper at the Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Canada. His main focus of research was transplantation of human ovarian tissue in immuno deficient mice. Upon returning to Israel in 1998, Prof. Weissman joined the IVF unit at the Department of Obstetrics and Gynecology, Wolfson Medical Center, Holon, Tel Aviv University Sackler Faculty of Medicine where he currently holds a position of an associate Professor. Together with David Gardner PhD, Colin Howles PhD, and Zeev Shoham M.D., Prof. Weissman has published the “Textbook of Assisted Techniques: Laboratory and Clinical Perspectives”, which is one of the leading books in the field of ART.
This site place cookies on your machine for reasons including keeping track of your preferences, collecting aggregated statistics to analyze how our site is used, and to show you ads tailored to your interests. ACCEPT
Privacy, Cookies Policy, General Terms and Conditions of Use
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.